MedTrace Logo

HLA-DR Expression in Neonates After Cardiac Surgery Under Cardiopulmonary Bypass

NCT03309839 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-09-24

No results posted yet for this study

Summary

The purpose of this study is to determine how monocyte HLA-DR and other markers of immune function change with time in neonates who underwent cardiac surgery with cardiopulmonary bypasss.

We hypothesize that HLA-DR expression in neonates is predictive of septic complications after cardiopulmonary bypass

Conditions

  • Cardiac Surgery

Interventions

OTHER

Blood collection

A sample of an additional blood tube will be taken in parallel with the blood test carried out for the treatment.

Sponsors & Collaborators

  • Fédération Française de Cardiologie

    collaborator OTHER

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Alexis Chenouard, Dr · Nantes University Hospital

Eligibility

Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-29
Primary Completion
2019-03-14
Completion
2019-04-13

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03309839 on ClinicalTrials.gov